Zobrazeno 1 - 10 of 19 pro vyhledávání: '"Perera ML"'
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
Re: Overall Survival with Adjuvant Pembrolizumab in Renal-cell Carcinoma.
Autor: Liu Z; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Urology, Tan Tock Seng Hospital, Singapore., AlSaffar H; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia., Perera S; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia., Mazzone E; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia., Lawrentschuk N; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Urology, Royal Melbourne Hospital, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Eapen R; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Murphy DG; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. Electronic address: declan.murphy@petermac.org., Perera ML; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Urology, Austin Health, Heidelberg, Australia.
Publikováno v: European urology [Eur Urol] 2024 Nov; Vol. 86 (5), pp. 482-483. Date of Electronic Publication: 2024 Jul 22.
Zobrazit plný text záznamu
4
Akademický článek
Re: Updated Analysis of Comparative Toxicity of Proton and Photon Radiation for Prostate Cancer.
Autor: Chen DC; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Urology, Austin Hospital, Heidelberg, Australia., Thomson A; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia., Mazzone E; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia., Perera ML; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Urology, Austin Hospital, Heidelberg, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Lawrentschuk N; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Department of Urology, Royal Melbourne Hospital, Melbourne, Australia., Siva S; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne Australia., Murphy DG; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. Electronic address: declan.murphy@petermac.org.
Publikováno v: European urology [Eur Urol] 2024 Sep 20. Date of Electronic Publication: 2024 Sep 20.
Zobrazit plný text záznamu
5
Akademický článek
Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
Autor: Chen DC; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia., AlSaffar H; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia., Graefen H; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Medical School Hamburg, University of Applied Sciences and Medical University, Hamburg, Germany., Perera S; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia., Mazzone E; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia., Perera ML; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Urology, Austin Health, Heidelberg, Australia., Lawrentschuk N; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Urology, Royal Melbourne Hospital, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Murphy DG; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. Electronic address: declan.murphy@petermac.org.
Publikováno v: European urology [Eur Urol] 2024 Sep; Vol. 86 (3), pp. 282-283. Date of Electronic Publication: 2024 Apr 16.
Zobrazit plný text záznamu
6
Akademický článek
Re: Artificial Intelligence and Radiologists in Prostate Cancer Detection on MRI (PI-CAI): An International, Paired, Non-inferiority, Confirmatory Study.
Autor: Chen DC; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Urology, Austin Health, Heidelberg, Australia., Park H; Department of Surgery, Alfred Health, Melbourne, Australia., McVey A; Department of Radiology, University Hospital, Geelong, Australia., Lawrentschuk N; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Department of Urology, Royal Melbourne Hospital, Melbourne, Australia., Perera ML; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Urology, Austin Health, Heidelberg, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Murphy DG; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. Electronic address: declan.murphy@petermac.org.
Publikováno v: European urology [Eur Urol] 2024 Aug 17. Date of Electronic Publication: 2024 Aug 17.
Zobrazit plný text záznamu
7
Akademický článek
Case of the Month from the Peter MacCallum Cancer Centre, Melbourne, Australia: an operative approach to large renal angiomyolipoma associated with lymphangioleiomyomatosis.
Autor: Chen DC; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.; Department of Urology, Austin Health, Heidelberg, Vic., Australia., O'Brien J; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia., Chen K; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia., Jenjitranant P; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia., Snow H; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia., Gyorki D; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia., Murphy DG; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Vic., Australia., Lawrentschuk N; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Vic., Australia.; Department of Urology, Royal Melbourne Hospital, Melbourne, Vic., Australia.; EJ Whitten Prostate Cancer Research Centre, Epworth HealthCare, Melbourne, Vic., Australia., Perera ML; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Vic., Australia.; Department of Urology, Royal Melbourne Hospital, Melbourne, Vic., Australia.; Department of Urology, Austin Health, Heidelberg, Vic., Australia., Kelly BD; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Vic., Australia.
Publikováno v: BJU international [BJU Int] 2024 Aug; Vol. 134 (2), pp. 187-191. Date of Electronic Publication: 2024 Jan 19.
Zobrazit plný text záznamu
8
Akademický článek
Re: [ 177 Lu]Lu-PSMA-617 plus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer (ENZA-p): An Open-label, Multicentre, Randomised, Phase 2 Trial.
Autor: Mazzone E; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Gianfranco Soldera Prostate Cancer Laboratory, Division of Oncology/Unit of Urology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Perera S; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia., Neti AL; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Barts and the London School of Medicine and Dentistry, London, UK., Chen DC; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia., Al-Saffar H; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia., Thomson A; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia., Perera ML; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Urology, Austin Hospital, Heidelberg, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Lawrentschuk N; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Department of Urology, Royal Melbourne Hospital, Melbourne, Australia., Murphy DG; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. Electronic address: declan.murphy@petermac.org.
Publikováno v: European urology [Eur Urol] 2024 Jul 19. Date of Electronic Publication: 2024 Jul 19.
Zobrazit plný text záznamu
9
Akademický článek
Re: Biomarker vs MRI-Enhanced Strategies for Prostate Cancer Screening. The STHLM3-MRI Randomized Clinical Trial.
Autor: Park H; Department of Urology, Alfred Health, Melbourne, Australia., Chen DC; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia., Mazzone E; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia., Grummet J; Department of Urology, Alfred Health, Melbourne, Australia., Perera ML; Department of Urology, Alfred Health, Melbourne, Australia; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia., Murphy DG; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. Electronic address: declan.murphy@petermac.org.
Publikováno v: European urology [Eur Urol] 2024 Jul 19. Date of Electronic Publication: 2024 Jul 19.
Zobrazit plný text záznamu
10
Editorial & Opinion
A critical evaluation of Optilume ® BPH as a novel minimally invasive surgical treatment for the management of lower urinary tract symptoms in men.
Autor: Chen DC; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Urology, Austin Health, Melbourne, Victoria, Australia.; Young Urological Researchers Organisation, Heidelberg, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Thomson A; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Huang S; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Murphy DG; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Bolton D; Department of Urology, Austin Health, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Lawrentschuk N; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Department of Urology, Royal Melbourne Hospital, Melbourne, Victoria, Australia., Perera ML; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Urology, Austin Health, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Department of Urology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Publikováno v: Translational andrology and urology [Transl Androl Urol] 2024 Apr 30; Vol. 13 (4), pp. 653-656. Date of Electronic Publication: 2024 Apr 11.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje